1 – 10 of 30
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas.
(
- Contribution to journal › Article
-
Mark
Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma.
(
- Contribution to journal › Article
- 2014
-
Mark
Comparison of neuropsychological and brain imaging data in pediatric brain tumor patients surviving more than 10 years
2014) 16th International Symposium on Pediatric Neuro-Oncology In Neuro-Oncology 16(Suppl 1). p.99-104(
- Contribution to journal › Article
-
Mark
Sequencing IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumors.
(
- Contribution to journal › Letter
-
Mark
Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer.
(
- Contribution to journal › Article
- 2013
-
Mark
Subsequent brain tumors in patients with autoimmune disease.
(
- Contribution to journal › Article
-
Mark
Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.
(
- Contribution to journal › Article
- 2012
-
Mark
Estimated clinical benefit of protecting neurogenesis in the developing brain during radiation therapy for pediatric medulloblastoma.
(
- Contribution to journal › Article
-
Mark
ANALYSIS OF CLUSTER OF DIFFERENTIATION (CD) MARKERS IN PEDIATRIC BRAIN TUMORS CAN BE USED AS A DIAGNOSTIC AND PROGNOSTIC TOOL
2012) 15th International Symposium on Pediatric Neuro-Oncology In Neuro-Oncology 14(suppl. 1). p.43-48(
- Contribution to journal › Published meeting abstract
- 2010
-
Mark
Plant thymidine kinase 1: a novel efficient suicide gene for malignant glioma therapy.
(
- Contribution to journal › Article